The article, "transcatheter closure of secundum atrial septal defects in pediatric patients: a 15-year single- center experience", was reviewed.The article presented a retrospective, single center study on the center's experience with transcatheter closure of atrial septal defects (asds) over the last 15 years.Devices included amplatzer septal occluder, occlutech figulla asd occluder, lifetech ceraflex, and solysafe septal occluder.The article concluded that with appropriate patient and device selection, transcatheter closure is a safe and effective treatment for secundum asd and should be the first treatment of choice.[the primary and corresponding author was eser dogan, department of pediatric cardiology, faculty of medicine, ege university, izmir, turkey, with corresponding email: eserdogan86@hotmail.Com].The time frame of the study was from january 2007 to january 2023.A total of 323 patients were included in this study, of which 277 (85.8%) received an abbott device.The average age was 8.08 years and the majority gender was female.Comorbidities included atrial septal defect (asd) including single or multiple secundum asds.
|